Fate Therapeutics (FATE) Price to Sales (2013 - 2026)
Fate Therapeutics' (FATE) Price to Sales stood at 48.54 in Q2 2026, up 220.2% from 15.16 a year earlier and up 119.7% from the prior quarter.
Powered by 
Analysis
Fate Therapeutics (FATE) Price to Sales (2013 - 2026) Analysis & Trends
For FY2025, Fate Therapeutics' Price to Sales came in at 17.01, up 23.3% from FY2024.
- Across earlier years, Price to Sales came in at 13.79 in FY2024 (+137.5%), 5.81 in FY2023 (-43.0%), 10.19 in FY2022 (-89.8%) and 100.29 in FY2021 (-60.5%).
- The Q2 2026 figure is the highest quarterly Price to Sales since Q1 2024.
- On a year-over-year basis, Price to Sales has increased for three consecutive quarters, with growth averaging 61.5% over the last seven quarters.
- Peak year-over-year performance for Price to Sales in the last five years was growth of 670.9% in Q2 2024, against a decline of 94.7% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at 22.09 (Q1 2026), 17.01 (Q4 2025) and 20.36 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Fate Therapeutics | 268.40 Mn | 268.40 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 48.54 |
| Mar 31, 2026 | 22.09 |
| Dec 31, 2025 | 17.01 |
| Sep 30, 2025 | 20.36 |
| Jun 30, 2025 | 15.16 |
| Mar 31, 2025 | 6.79 |
| Dec 31, 2024 | 13.79 |
| Sep 30, 2024 | 29.64 |
| Jun 30, 2024 | 30.32 |
| Mar 31, 2024 | 128.94 |
| Dec 31, 2023 | 5.81 |
| Sep 30, 2023 | 1.97 |
| Jun 30, 2023 | 3.93 |
| Mar 31, 2023 | 4.09 |
| Dec 31, 2022 | 10.19 |
| Sep 30, 2022 | 31.53 |
| Jun 30, 2022 | 35.17 |
| Mar 31, 2022 | 59.30 |
| Dec 31, 2021 | 100.29 |
| Sep 30, 2021 | 103.38 |
API Access
Fate Therapeutics Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=FATE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "FATE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=FATE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();